IMM Private Equity, one of South Korea’s largest private equity firms, has called off its plan to acquire CGBio Co., a spine and wound-care materials maker owned by Daewoong Pharmaceutical Co., after the two sides failed to resolve disagreements over a couple of contract clauses.